The U.S. Defense Health Agency has awarded a $7,733,625.25 cost-plus-fixed-fee contract to Mantel Technologies, Inc. for Phase III Small Business Innovation Research (SBIR) research and development of a "Canine Freeze Dried Plasma System." This definitive contract has a completion date of September 15, 2025. Mantel Technologies, Inc. is a small business manufacturer that has previously received federal contract and grant awards from the Department of Defense and Department of Energy for products and R&D related to military personnel readiness and operational capabilities. This SBIR Phase III award indicates the technology has progressed through prior SBIR phases and is now being developed further for potential military application.
Generated 6/25/24, 2:13 PM